{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T06:41:09Z","timestamp":1740120069513,"version":"3.37.3"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T00:00:00Z","timestamp":1715990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T00:00:00Z","timestamp":1715990400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Japanese Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"crossref","award":["16K09820"],"award-info":[{"award-number":["16K09820"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["16ek0109043h0003"],"award-info":[{"award-number":["16ek0109043h0003"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Japanese Ministry of Health, Labor, and Welfare","award":["21FC1008"],"award-info":[{"award-number":["21FC1008"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1007\/s12185-024-03782-4","type":"journal-article","created":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T11:01:50Z","timestamp":1716030110000},"page":"375-381","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Retrospectively diagnosed autoimmune VWF deficiency in a patient with repeated hemorrhagic events after two common colds"],"prefix":"10.1007","volume":"120","author":[{"given":"Yoshiyuki","family":"Ogawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3807-5628","authenticated-orcid":false,"given":"Akitada","family":"Ichinose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunio","family":"Yanagisawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayoshi","family":"Souri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsukasa","family":"Osaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuhei","family":"Kanaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Handa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,5,18]]},"reference":[{"key":"3782_CR1","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000586","volume":"5","author":"FWG Leebeek","year":"2021","unstructured":"Leebeek FWG. New developments in diagnosis and management of acquired hemophilia and acquired von Willebrand syndrome. Hemasphere. 2021;5: e586.","journal-title":"Hemasphere"},{"key":"3782_CR2","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1055\/s-0042-1749088","volume":"48","author":"A Ichinose","year":"2022","unstructured":"Ichinose A, Osaki T, Souri M, Favaloro EJ. A review of autoimmune acquired von Willebrand factor deficiency in Japan. Semin Thromb Hemost. 2022;48:911\u201325.","journal-title":"Semin Thromb Hemost"},{"key":"3782_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcmd.2020.102526","volume":"87","author":"B Panholzer","year":"2021","unstructured":"Panholzer B, Bajorat T, Haneya A, Kowalski D, Juhl D, Rocke A, et al. Acquired von Willebrand syndrome in ECMO patients: a 3-year cohort study. Blood Cells Mol Dis. 2021;87: 102526.","journal-title":"Blood Cells Mol Dis"},{"key":"3782_CR4","doi-asserted-by":"publisher","first-page":"6777","DOI":"10.1182\/blood-2010-11-297580","volume":"117","author":"A Tiede","year":"2011","unstructured":"Tiede A, Rand JH, Budde U, Ganser A, Federici AB. How I treat the acquired von Willebrand syndrome. Blood. 2011;117:6777\u201385.","journal-title":"Blood"},{"key":"3782_CR5","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1055\/s-0033-1334867","volume":"39","author":"AB Federici","year":"2013","unstructured":"Federici AB, Budde U, Castaman G, Rand JH, Tiede A. Current diagnostic and therapeutic approaches to patients with acquired von Willebrand syndrome: a 2013 update. Semin Thromb Hemost. 2013;39:191\u2013201.","journal-title":"Semin Thromb Hemost"},{"issue":"Suppl 5","key":"3782_CR6","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/hae.12984","volume":"22","author":"AH James","year":"2016","unstructured":"James AH, Eikenboom J, Federici AB. State of the art: von Willebrand disease. Haemophilia. 2016;22(Suppl 5):54\u20139.","journal-title":"Haemophilia"},{"key":"3782_CR7","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1055\/a-2002-2394","volume":"123","author":"T Osaki","year":"2023","unstructured":"Osaki T, Souri M, Yokoyama C, Magari Y, Ichinose A. Unmet need for reliable immunological detection method for anti-von Willebrand factor autoantibodies. Thromb Haemost. 2023;123:478\u201381.","journal-title":"Thromb Haemost"},{"key":"3782_CR8","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1111\/hae.14298","volume":"27","author":"A Ichinose","year":"2021","unstructured":"Ichinose A, Osaki T, Souri M. Pathological coagulation parameters in as many as 54 patients with autoimmune acquired factor XIII deficiency due to anti-factor XIII autoantibodies. Haemophilia. 2021;27:454\u201362.","journal-title":"Haemophilia"},{"key":"3782_CR9","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.thromres.2022.03.006","volume":"213","author":"T Osaki","year":"2022","unstructured":"Osaki T, Souri M, Ogawa Y, Sato H, Mitsui T, Ichinose A. Retrospective examination of coagulation parameters in 33 patients with autoimmune coagulation factor deficiencies in Japan: a single-center analysis. Thromb Res. 2022;213:154\u201362.","journal-title":"Thromb Res"},{"key":"3782_CR10","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1089\/mab.2019.0008","volume":"38","author":"C Yokoyama","year":"2019","unstructured":"Yokoyama C, Ikeda S, Osaki T, Souri M, Ichinose A. Generation and application of rat monoclonal antibodies specific for a human blood coagulation protein: von Willebrand factor. Monoclon Antib Immunodiagn Immunother. 2019;38:133\u20136.","journal-title":"Monoclon Antib Immunodiagn Immunother"},{"key":"3782_CR11","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s12185-017-2210-8","volume":"106","author":"Y Ogawa","year":"2017","unstructured":"Ogawa Y, Yanagisawa K, Uchiumi H, Ishizaki T, Mitsui T, Gouda F, et al. Clinical characteristics and outcomes of acquired hemophilia A: experience at a single center in Japan. Int J Hematol. 2017;106:82\u20139.","journal-title":"Int J Hematol"},{"key":"3782_CR12","doi-asserted-by":"publisher","first-page":"e121","DOI":"10.1111\/hae.14613","volume":"28","author":"A Ichinose","year":"2022","unstructured":"Ichinose A, Osaki T, Souri M. Autoimmune acquired factor XIII deficiency in Japan 2021 update: focused on annual incidence and clinical features. Haemophilia. 2022;28:e121\u20134.","journal-title":"Haemophilia"},{"key":"3782_CR13","doi-asserted-by":"crossref","unstructured":"Ichinose A, Osaki T, Souri M. A review of coagulation abnormalities of autoimmune acquired factor V deficiency with a focus on Japan. Semin Thromb Hemost. 2022;48:206\u201318. Erratum in: Semin Thromb Hemost. 2022;48(2):e1.","DOI":"10.1055\/s-0041-1740149"},{"key":"3782_CR14","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.lungcan.2021.03.021","volume":"155","author":"T Sumi","year":"2021","unstructured":"Sumi T, Nakata H, Chiba H. Squamous cell carcinoma associated with acquired von Willebrand disease due to immune checkpoint inhibitor treatment. Lung Cancer. 2021;155:196\u20138.","journal-title":"Lung Cancer"},{"key":"3782_CR15","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1097\/MBC.0000000000001244","volume":"34","author":"WJ Archibald","year":"2023","unstructured":"Archibald WJ, Kouides PA, Refaai MA, Lachant NA. Acquired bleeding disorders secondary to immune checkpoint inhibitors: a case report and systematic literature review. Blood Coagul Fibrinolysis. 2023;34:427\u201331.","journal-title":"Blood Coagul Fibrinolysis"},{"key":"3782_CR16","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s40792-023-01601-2","volume":"9","author":"S Arakaki","year":"2023","unstructured":"Arakaki S, Ono S, Kawamata F, Ishino S, Uesato Y, Nakajima T, et al. Fatal acquired coagulation factor V deficiency after hepatectomy for advanced hepatocellular carcinoma as a possible immune checkpoint inhibitor-related adverse event: a case report. Surg Case Rep. 2023;9:16.","journal-title":"Surg Case Rep"},{"key":"3782_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/rth2.12700","volume":"6","author":"JW Jacobs","year":"2022","unstructured":"Jacobs JW, Adkins BD, Walker SC, Booth GS, Wheeler AP. Coagulation factor inhibitors in COVID-19: From SARS-CoV-2 vaccination to infection. Res Pract Thromb Haemost. 2022;6: e12700.","journal-title":"Res Pract Thromb Haemost"},{"key":"3782_CR18","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/ajh.26426","volume":"97","author":"S Shimoyama","year":"2022","unstructured":"Shimoyama S, Kanisawa Y, Ono K, Souri M, Ichinose A. First and fatal case of autoimmune acquired factor XIII\/13 deficiency after COVID-19\/SARS-CoV-2 vaccination. Am J Hematol. 2022;97:243\u20135.","journal-title":"Am J Hematol"},{"key":"3782_CR19","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1055\/a-1863-7265","volume":"122","author":"S Nakamura","year":"2022","unstructured":"Nakamura S, Sugasaki M, Souri M, Akazawa H, Sogawa M, Hori T, Yamagami H, Takishita M, Aihara KI, Abe M, Yasumoto A, Morishita E, Ichinose A. Autoimmune acquired factor XIII\/13 deficiency after SARS-CoV-2 mRNA vaccination. Thromb Haemost. 2022;122:1837\u201342.","journal-title":"Thromb Haemost"},{"key":"3782_CR20","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1111\/jth.15665","volume":"20","author":"JR Hirsiger","year":"2022","unstructured":"Hirsiger JR, Martinez M, Tsakiris DA, Cittone MG, Graf L, Oldenburg J, et al. Investigating potential mechanisms underlying FVIII inhibition in acquired hemophilia A associated with mRNA COVID-19 vaccines. J Thromb Haemost. 2022;20:1015\u20138.","journal-title":"J Thromb Haemost"},{"key":"3782_CR21","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.1111\/jth.15421","volume":"19","author":"MG Cittone","year":"2021","unstructured":"Cittone MG, Battegay R, Condoluci A, Terzi di Bergamo L, Fernandes E, Galfetti EN, et al. The statistical risk of diagnosing coincidental acquired hemophilia A following anti-SARS-CoV-2 vaccination. J Thromb Haemost. 2021;19:2360\u20132.","journal-title":"J Thromb Haemost"},{"key":"3782_CR22","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1002\/jha2.604","volume":"4","author":"F Amisha","year":"2023","unstructured":"Amisha F, Saluja P, Malik P, Van Rhee F. Acquired hemophilia A (AHA) due to anti-SARS-CoV-2 vaccination: a systematic review. EJHaem. 2023;4:532\u201343.","journal-title":"EJHaem"},{"key":"3782_CR23","doi-asserted-by":"publisher","first-page":"2794","DOI":"10.1182\/bloodadvances.2021004957","volume":"5","author":"AJ Portuguese","year":"2021","unstructured":"Portuguese AJ, Sunga C, Kruse-Jarres R, Gernsheimer T, Abkowitz J. Autoimmune- and complement-mediated hematologic condition recrudescence following SARS-CoV-2 vaccination. Blood Adv. 2021;5:2794\u20138.","journal-title":"Blood Adv"},{"key":"3782_CR24","first-page":"933","volume":"44","author":"M Hasegawa","year":"2003","unstructured":"Hasegawa M, Tanaka T, Kii T, Fujiwara S, Ikeda N, Kinntaka D, et al. Acquired inhibitor against coagulation factor V with severe hematuria. Rinsho Ketsueki. 2003;44:933\u20139.","journal-title":"Rinsho Ketsueki"},{"key":"3782_CR25","doi-asserted-by":"publisher","first-page":"520","DOI":"10.3389\/fimmu.2014.00520","volume":"5","author":"G Vidarsson","year":"2014","unstructured":"Vidarsson G, Dekkers G, Rispens T. IgG subclasses and allotypes: from structure to effector functions. Front Immunol. 2014;5:520.","journal-title":"Front Immunol"},{"issue":"8 Suppl","key":"3782_CR26","first-page":"S16","volume":"9","author":"A Ferrante","year":"1990","unstructured":"Ferrante A, Beard LJ, Feldman RG. IgG subclass distribution of antibodies to bacterial and viral antigens. Pediatr Infect Dis J. 1990;9(8 Suppl):S16-24.","journal-title":"Pediatr Infect Dis J"},{"key":"3782_CR27","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.it.2019.01.005","volume":"40","author":"T Damelang","year":"2019","unstructured":"Damelang T, Rogerson SJ, Kent SJ, Chung AW. Role of IgG3 in infectious diseases. Trends Immunol. 2019;40:197\u2013211.","journal-title":"Trends Immunol"},{"key":"3782_CR28","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/ncomms1608","volume":"2","author":"NM Stapleton","year":"2011","unstructured":"Stapleton NM, Andersen JT, Stemerding AM, Bjarnarson SP, Verheul RC, Gerritsen J, et al. Competition for FcRn-mediated transport gives rise to short half-life of human IgG3 and offers therapeutic potential. Nat Commun. 2011;2:599.","journal-title":"Nat Commun"},{"key":"3782_CR29","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.imlet.2014.01.015","volume":"160","author":"R Kapur","year":"2014","unstructured":"Kapur R, Einarsdottir HK, Vidarsson G. IgG-effector functions: \u201cthe good, the bad and the ugly.\u201d Immunol Lett. 2014;160:139\u201344.","journal-title":"Immunol Lett"},{"key":"3782_CR30","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/S0022-3476(05)82413-8","volume":"119","author":"S Kinoshita","year":"1991","unstructured":"Kinoshita S, Yoshioka K, Kasahara M, Takamiya O. Acquired von Willebrand disease after Epstein-Barr virus infection. J Pediatr. 1991;119:595\u20138.","journal-title":"J Pediatr"},{"key":"3782_CR31","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1002\/ajh.2830490114","volume":"49","author":"G Castaman","year":"1995","unstructured":"Castaman G, Lattuada A, Mannucci PM, Rodeghiero F. Characterization of two cases of acquired transitory von Willebrand syndrome with ciprofloxacin: evidence for heightened proteolysis of von Willebrand factor. Am J Hematol. 1995;49:83\u20136.","journal-title":"Am J Hematol"},{"key":"3782_CR32","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1159\/000529740","volume":"146","author":"M Iarossi","year":"2023","unstructured":"Iarossi M, Hermans C. Acquired Von Willebrand Syndrome following a SARS-CoV2 Infection. Acta Haematol. 2023;146:226\u20139.","journal-title":"Acta Haematol"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-024-03782-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-024-03782-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-024-03782-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T11:30:38Z","timestamp":1724931038000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-024-03782-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,18]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["3782"],"URL":"https:\/\/doi.org\/10.1007\/s12185-024-03782-4","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"type":"print","value":"0925-5710"},{"type":"electronic","value":"1865-3774"}],"subject":[],"published":{"date-parts":[[2024,5,18]]},"assertion":[{"value":"19 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There are no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"Informed consent was obtained from the patient and her family.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent statement"}}]}}